Zy. Li et al., INHIBITION OF LPS-INDUCED TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY COLCHICINE AND OTHER MICROTUBULE DISRUPTING DRUGS, Immunobiology, 195(4-5), 1996, pp. 624-639
Colchicine has been shown to act as an antiinflammatory agent. In this
study, we examined a whether colchicine and other microtubule-depolym
erizing drugs affected the production of TNF-alpha. When rat peritonea
l macrophages were stimulated by LPS, addition of colchicine, vincrist
ine, vinblastine or nocodazole was found to inhibit TNF-alpha release
in a concentration-dependent manner. Suppression of TNF-alpha release
was not due to interference with secretion as the cytokine did not acc
umulate intracellularly following colchicine treatment. Colchicine mar
kedly enhanced PGE(2) release from LPS-stimulated macrophages. However
, addition of the cyclooxygenase inhibitor indomethacin only partially
reversed the suppressive effect of colchicine on TNF-alpha production
. Colchicine caused a strong reduction of LPS-induced TNF-alpha mRNA a
ccumulation, suggesting that a pretranslational effect may represent t
he primary mechanism by which colchicine reduced TNF-alpha production.
These observations could have clinical relevance in ameliorating unde
sirable effects due to excessive TNF-alpha production, for example fol
lowing LPS stimulation of monocytes/macrophages in gram-negative sepsi
s. Furthermore, these drugs may provide useful tools to study the appa
rent involvement of the microtubular system in cytokine gene expressio
n and cytokine production.